Renalytix RNLX reported its Q1 earnings results on Tuesday, November 14, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Renalytix missed estimated earnings by 10.0%, reporting an EPS of $-0.11 versus an estimate of $-0.1.
Revenue was down $510 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 5.96% increase in the share price the next day.
Here's a look at Renalytix's past performance:
| Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|
| EPS Estimate | -0.13 | -0.11 | -0.14 | -0.13 | -0.19 |
| EPS Actual | -0.11 | -0.14 | -0.14 | -0.16 | -0.22 |
| Revenue Estimate | 720K | 1.28M | 1.28M | 1.10M | 800K |
| Revenue Actual | 518K | 724K | 1.19M | 969K | 831K |
To track all earnings releases for Renalytix visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
